Literature DB >> 28465276

Management of Glioblastoma Multiforme in Elderly Patients: A Review of the Literature.

Sameer H Halani1, Ranjith Babu2, D Cory Adamson3.   

Abstract

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults, occurs most commonly in individuals older than 65 years of age, and is universally fatal. Increasing age compounds the poor prognosis of GBM, as elderly patients have markedly worse outcomes than younger patients. However, many of the studies previously investigating optimal treatment regimens exclude patients older than the age of 65 years and thus may not represent the best approaches to ensuring prolonged survival with preserved quality of life. This review aims to highlight the current literature on surgical and medical management, including our own experience, for GBM in the elderly patients, and to provide rational treatment approaches for a vulnerable, often-overlooked, patient population.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Elderly; Extent of resection; GBM; Glioblastoma; Literature review; Temozolomide

Mesh:

Substances:

Year:  2017        PMID: 28465276     DOI: 10.1016/j.wneu.2017.04.153

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis.

Authors:  Brandon A Sherrod; Nicholas T Gamboa; Christopher Wilkerson; Herschel Wilde; Mohammed A Azab; Michael Karsy; Randy L Jensen; Sarah T Menacho
Journal:  J Neurooncol       Date:  2019-05-04       Impact factor: 4.130

2.  Glioblastoma Survival Outcomes at a Tertiary Hospital in Appalachia: Factors Impacting the Survival of Patients Following Implementation of the Stupp Protocol.

Authors:  Ogaga Urhie; Ryan Turner; Brandon Lucke-Wold; Walid Radwan; Janice Ahn; Kymberly Gyure; Sanjay Bhatia
Journal:  World Neurosurg       Date:  2018-04-06       Impact factor: 2.104

3.  Do elderly patients (≥ 75 years old) with glioblastoma benefit from more radical surgeries in the era of temozolomide?

Authors:  Tengfei Li; Yanhui Liu; Junhong Li; Mingrong Zuo; Yongzhong Cheng
Journal:  Neurosurg Rev       Date:  2021-07-09       Impact factor: 3.042

4.  Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study.

Authors:  Yong Wang; Xiangji Meng; Shizhen Zhou; Yufang Zhu; Jun Xu; Rongjie Tao
Journal:  Onco Targets Ther       Date:  2019-12-03       Impact factor: 4.147

Review 5.  Palliative care of older glioblastoma patients in neurosurgery.

Authors:  Daniel Berthold; Anna Pedrosa Carrasco; Eberhard Uhl; Heidi Müller; Rio Dumitrascu; Ulf Sibelius; Holger Hauch
Journal:  J Neurooncol       Date:  2022-03-24       Impact factor: 4.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.